SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?


To: Clarksterh who wrote (2250)8/23/2013 9:22:45 AM
From: scaram(o)uche  Respond to of 2344
 
Don't have a clue what you're talking about.

Are you Jake King? I thought your name was Clark??

Moreover, I thanked those who I "cribbed" from, biomachine and AVI.

Did you once estimate that there were more than 4 (or 8, if you like) cuts through the data? Was the 40 or 100 number originally yours? If you did, then I'm certainly not referring to such. I'm referring to numbers that I saw at Twitter. If you once estimated a higher number, then get past it. Thanks.

I have a decent bkgd in both immunology and stats, I certainly feel no compulsion to crib from your dear thread.



To: Clarksterh who wrote (2250)8/23/2013 9:38:40 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 2344
 
>> Even if you think the ONTY/Merck management is Data-like in their rationality <<

Neither you nor I have had any exposure to any data grooming from either Merck or ONTY. Are you accusing Dr. Butts and collaborators of irrational (or worse) grooming of data?